4-OHT treatment at E8.5 and E9.5, which coincides with the timing of Wnt1-Cre2 activity, induced severe vascular defects, including carotid artery aneurysm by E13.5 (Fig. 7a–c). The gene discussed is WNT1; the disease is aortic aneurysm.